CEACAM5 and neoplasm: The latest European Society for Medical Oncology (ESMO) guidelines include lymph node sampling <12 and T4 stage including perforation as major prognostic factors and high-grade tumor, vascular invasion, lymphatic invasion, perineural invasion, tumor presentation with obstruction, and high preoperative carcinoembryonic antigen (CEA) levels as minor prognostic factors.